Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.814.86-11.939.9461.19

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 19.81 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.81
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.81
307.61
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,725.2 Cr -1.8% -5% 33.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,978.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 1.2% 10.2% 4.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-1.8%

-5%

33.4%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses